Statistical inference methods for two crossing survival curves: a comparison of methods
- PMID: 25615624
- PMCID: PMC4304842
- DOI: 10.1371/journal.pone.0116774
Statistical inference methods for two crossing survival curves: a comparison of methods
Abstract
A common problem that is encountered in medical applications is the overall homogeneity of survival distributions when two survival curves cross each other. A survey demonstrated that under this condition, which was an obvious violation of the assumption of proportional hazard rates, the log-rank test was still used in 70% of studies. Several statistical methods have been proposed to solve this problem. However, in many applications, it is difficult to specify the types of survival differences and choose an appropriate method prior to analysis. Thus, we conducted an extensive series of Monte Carlo simulations to investigate the power and type I error rate of these procedures under various patterns of crossing survival curves with different censoring rates and distribution parameters. Our objective was to evaluate the strengths and weaknesses of tests in different situations and for various censoring rates and to recommend an appropriate test that will not fail for a wide range of applications. Simulation studies demonstrated that adaptive Neyman's smooth tests and the two-stage procedure offer higher power and greater stability than other methods when the survival distributions cross at early, middle or late times. Even for proportional hazards, both methods maintain acceptable power compared with the log-rank test. In terms of the type I error rate, Renyi and Cramér-von Mises tests are relatively conservative, whereas the statistics of the Lin-Xu test exhibit apparent inflation as the censoring rate increases. Other tests produce results close to the nominal 0.05 level. In conclusion, adaptive Neyman's smooth tests and the two-stage procedure are found to be the most stable and feasible approaches for a variety of situations and censoring rates. Therefore, they are applicable to a wider spectrum of alternatives compared with other tests.
Conflict of interest statement
Figures
Similar articles
-
A win ratio approach for comparing crossing survival curves in clinical trials.J Biopharm Stat. 2023 Jul 4;33(4):488-501. doi: 10.1080/10543406.2023.2170393. Epub 2023 Feb 7. J Biopharm Stat. 2023. PMID: 36749067
-
Partitioned log-rank tests for the overall homogeneity of hazard rate functions.Lifetime Data Anal. 2017 Jul;23(3):400-425. doi: 10.1007/s10985-016-9365-0. Epub 2016 Mar 19. Lifetime Data Anal. 2017. PMID: 26995734
-
Simulating survival data with predefined censoring rates for proportional hazards models.Stat Med. 2017 Feb 28;36(5):838-854. doi: 10.1002/sim.7178. Epub 2016 Nov 21. Stat Med. 2017. PMID: 27873333
-
Which test for crossing survival curves? A user's guideline.BMC Med Res Methodol. 2022 Jan 30;22(1):34. doi: 10.1186/s12874-022-01520-0. BMC Med Res Methodol. 2022. PMID: 35094686 Free PMC article. Review.
-
Group sequential tests for long-term survival comparisons.Lifetime Data Anal. 2015 Apr;21(2):218-40. doi: 10.1007/s10985-014-9298-4. Epub 2014 Jul 23. Lifetime Data Anal. 2015. PMID: 25053470 Free PMC article. Review.
Cited by
-
Longer time to testosterone recovery impacts favorably on outcomes for prostate cancer following androgen deprivation and radiotherapy.Strahlenther Onkol. 2024 Feb 28. doi: 10.1007/s00066-024-02208-8. Online ahead of print. Strahlenther Onkol. 2024. PMID: 38416163
-
An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.J Cancer Res Clin Oncol. 2024 Feb 12;150(2):91. doi: 10.1007/s00432-024-05606-8. J Cancer Res Clin Oncol. 2024. PMID: 38347320 Free PMC article.
-
PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma.Oncol Lett. 2024 Jan 19;27(3):109. doi: 10.3892/ol.2024.14242. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38304170 Free PMC article.
-
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality Risk.J Am Heart Assoc. 2024 Jan 16;13(2):e031646. doi: 10.1161/JAHA.123.031646. Epub 2024 Jan 12. J Am Heart Assoc. 2024. PMID: 38214281 Free PMC article.
-
CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.Oncol Rep. 2024 Feb;51(2):35. doi: 10.3892/or.2024.8694. Epub 2024 Jan 8. Oncol Rep. 2024. PMID: 38186304 Free PMC article.
References
-
- Qiu P, Sheng J (2008) A two-stage procedure for comparing hazard rate functions. J R Statist Soc B 70(1): 191–208.
-
- Lin X, Wang H (2004) A new testing approach for comparing the overall homogeneity of survival curves. Biometrical J 46(5): 489–496. 10.1002/bimj.200310053 - DOI
-
- Le CT (2003) Statistical methods for the comparison of crossing survival curves. In: Balakrishnan N and Rao CR (eds) Handbook of Statistics, Vol.23 Amsterdam: Elsevier, pp.277–289.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
